指南与共识重症综合管理与镇静镇痛儿科与产科急症

儿童急性肺损伤与脓毒症研究者及儿童血液与骨髓移植联盟联合工作委员会共识报告:儿童及青少年肝窦阻塞综合征支持治疗指南,第1部分:聚焦检查、预防与特异性治疗

Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.
指南 / 共识 · Biol Blood Marrow Transplant · 2017-07-25
一句话结论儿童造血干细胞移植后肝窦阻塞综合征(VOD)发生率约三分之一,重型病死率50%,去纤苷早期特异性治疗可改善结局,但支持治疗缺乏指南且管理差异大。

肝窦阻塞综合征(VOD)是儿童造血干细胞移植(HCT)后常见且可能致命的并发症,约三分之一移植患者发生,重型患者病死率50%。早期干预和去纤苷特异性治疗与结局改善相关,但针对多器官功能障碍的支持治疗缺乏指南,管理差异大,可能增加发病率和死亡率。儿童急性肺损伤与脓毒症研究者及儿童血液与骨髓移植联盟联合工作委员会合作,采用GRADE标准制定系列循证支持治疗指南。本文为第1部分,聚焦制定指南的必要性、方法学以及儿童VOD诊断、预防和治疗所需的检查。

要点

  • 儿童HCT后VOD发生率约三分之一,重型VOD病死率达50%。
  • 早期干预和去纤苷特异性治疗与结局改善相关。
  • VOD支持治疗(腹水、输血、液体电解质、谵妄、检查)缺乏文献和指南,管理差异大。
  • 本指南由儿童急性肺损伤与脓毒症研究者及儿童血液与骨髓移植联盟联合制定,采用GRADE分级。
  • 第1部分聚焦VOD诊断、预防和治疗所需的检查。

适用人群与场景

  • 接受造血干细胞移植(HCT)的儿童及青少年。

研究设计与关键结果

  • 儿童HCT后VOD发生率约三分之一,重型VOD病死率50%。
  • 早期干预和去纤苷特异性治疗与结局改善相关。
  • VOD支持治疗相关文献匮乏,管理差异大,可能增加发病率和死亡率。

证据类型、等级与局限

  • 证据类型:共识指南,采用GRADE标准对证据质量进行评级并形成推荐。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为需要制定儿童VOD支持治疗循证指南以减少管理差异。
  • 本文为系列第1部分,聚焦VOD诊断、预防和治疗所需的检查。

指南或共识出处

  • 儿童急性肺损伤与脓毒症研究者与儿童血液与骨髓移植联盟联合工作委员会共识报告,发表于Biol Blood Marrow Transplant。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Veno-occlusive disease (VOD) is a common and potentially fatal complication in children undergoing hematopoietic cell transplantation (HCT). It occurs in about one-third of all patients undergoing transplantation and is fatal in 50% of patients with severe disease. Early intervention and specific treatment with defibrotide are associated with improved outcomes. However, there is a lack of supportive care guidelines for management of the multiorgan dysfunction seen in most cases. There is high variability in the management of VOD, which may contribute to the increased morbidity and mortality. Although there is ample research in the specific treatment of VOD, there is paucity of literature regarding the management of ascites, transfusions requirements, fluids and electrolyte dysfunction, delirium, and investigations in children with VOD. The joint working committees of the Pediatric Acute Lung Injury and Sepsis Investigators and the Pediatric Blood and Marrow Transplantation Consortium collaborated to develop a series of evidence-based supportive care guidelines for management of VOD. The quality of evidence was rated and recommendations were made using Grading of Recommendations, Assessment, Development and Evaluation criteria. This manuscript is part 1 of the series and focuses on the need to develop these guidelines; methodology used to establish the guidelines; and investigations needed for diagnosis, prophylaxis, and treatment of VOD in children.

来源:Biol Blood Marrow Transplant,查看原文。版权归原作者所有。

参考来源

  1. Bajwa RPS, Mahadeo KM, Taragin BH, et al. Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment. Biol Blood Marrow Transplant. 2017. PMID: 28754544. doi:10.1016/j.bbmt.2017.07.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。